People: Regeneron Pharmaceuticals Inc (REGN.O)
24 May 2013
Dr. Michael Aberman, M.D., is Vice President - Strategy and Investor Relations of Regeneron Pharmaceuticals, Inc., since March 23, 2010. Prior to joining the Company, he spent six years as a Wall Street analyst covering the biotechnology industry. From March 2006 until joining the Company, he was Director and Senior Biotechnology Analyst at Credit Suisse. Prior to that, from March 2004 until March 2006, he worked as a Biotechnology Analyst at Morgan Stanley, Inc. From February 2002 through March 2004, Dr. Aberman was Director of Business Development at Antigenics Inc., an oncology-focused biotechnology company. Dr. Aberman received his M.D. with honors from the University of Toronto and his M.B.A. from the Wharton School of the University of Pennsylvania.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|